| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Total revenues | 28 | |||
| Cost of revenues | 0 | |||
| Research and development expenses | 923 | |||
| Selling, general and administrative expenses | 1,740 | |||
| Total costs and expenses | 2,663 | |||
| Loss from operations | -2,635 | |||
| Interest income | 92 | |||
| Interest expense | 0 | |||
| Total other income | 92 | |||
| Income tax expense | 2 | |||
| Net loss | -2,545 | |||
| Unrealized gain on available-for-sale debt securities | 0 | |||
| Comprehensive loss | -2,545 | |||
| Earnings per share, basic, total | -0.98 | |||
| Earnings per share, diluted, total | -0.98 | |||
| Weighted average number of shares outstanding, basic, total | 2,604,950 | |||
| Weighted average number of shares outstanding, diluted, total | 2,604,950 | |||
VivoSim Labs, INC. (VIVS)
VivoSim Labs, INC. (VIVS)